BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3362404)

  • 1. Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
    Perry TL; Jones K; Hansen S
    Neurosci Lett; 1988 Feb; 85(1):101-4. PubMed ID: 3362404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL; Jones K; Hansen S; Wall RA
    Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
    Ishiwata K; Koyanagi Y; Abe K; Kawamura K; Taguchi K; Saitoh T; Toda J; Senda M; Sano T
    J Neurochem; 2001 Nov; 79(4):868-76. PubMed ID: 11723179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
    Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Wall RA; Jones K
    Neurosci Lett; 1986 Sep; 69(3):285-9. PubMed ID: 3489912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
    Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
    Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
    Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T; Mizuno Y; Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Oct; 92(3):321-4. PubMed ID: 3200488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
    Kuhlmann AC; Guilarte TR
    Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
    Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventative effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives (
    Munakata H; Ishikawa R; Saitoh T; Kambe T; Chiba T; Taguchi K; Abe K
    Can J Physiol Pharmacol; 2022 Jul; 100(7):594-611. PubMed ID: 35413210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.
    Yong VW; Perry TL; Krisman AA
    Neurosci Lett; 1986 Jan; 63(1):56-60. PubMed ID: 3485266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-cyclohexyl- and 1-cyclohexyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on dopaminergic spontaneous discharge in nigral neurons of rats.
    Abe M; Munakata H; Abe K; Saito T; Horiguchi Y; Nojima H; Taguchi K
    Brain Res Bull; 2016 Mar; 121():201-8. PubMed ID: 26876935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
    Yoshida M; Ogawa M; Suzuki K; Nagatsu T
    Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.